Member Info for Timster

and no news in October mention :)

glad you're all paying attention I meant 2000%

and yes for balance if its a TT fail RNS then 100% down

have a feeling those who want to be in are in and the rest are waiting in the wings for an RNS

you'd end up paying 20% more though by the time you could by on a great RNS IMO

.

thought I'd post again

https://avacta.com/interim-results-for-the-period-ended-30-june-2020-webinar-presentation/

40 mins in is all about tech transfer

they've also added some of the Q&A at the end

I cant hear it have you got a time in the recording??
https://avacta.com/interim-results-for-the-period-ended-30-june-2020-webinar-presentation/

I think Ophidian and them all went off to twitter as the board had descended into complete chaos one weekend

https://avacta.com/

there we go, hope that helps

who cares!

only thing that maters is RNS's from the company and communication from big AL

I'm very positive that will come

Q4 they said could be major inflection points. they never said October

It will be us eventually its a matter of time and patience

They'll be news unearthed at the weekend "must be us" 1000's of excited posts. Next week, silence ;)

NO

maybe an RSI

that's for the delivery and collection and all the logistics.

Medusa will be all over it ;)

.

.

Until we have an RNS confirming the 10K validation batch is complete.

from this we will be given timeframes thorough validation, CE marking and product launch!

The CEO of Avacta has stated he will not rush this and risk developing a poorly performing test..

its not ours, we knew it was crap

Want to know how good they are and how easy they are to produce:
https://avacta.com/therapeutics/affimer-technology/

look at the data Avacta have provided around the COVID-19 ELISA test and the Bruker note for bams:

https://www.bruker.com/fileadmin/user_upload/8-PDF-Docs/Separations_MassSpectrometry/Literature/ApplicationNotes/1881181_MT-128_SARS-CoV-2_Antigen_Assay_ebook.pdf

https://avacta.com/alastair-smith-gives-more-detail-on-the-sars-cov-2-elisa-laboratory-test/